Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CLOFIBRATE: 81 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
81
Total FAERS Reports
0
Deaths Reported
68
Hospitalizations
81
As Primary/Secondary Suspect
9
Disabilities
Approved Prior to Jan 1, 1982
FDA Approved
Discontinued
Status
Yes
Generic Available

FDA Application: 016099 ·

First Report: 20141031 · Latest Report: 20230810

What Are the Most Common CLOFIBRATE Side Effects?

#1 Most Reported
Pain
73 reports (90.1%)
#2 Most Reported
Therapeutic product effect incomplete
64 reports (79.0%)
#3 Most Reported
Procedural pain
64 reports (79.0%)

All CLOFIBRATE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Pain 73 90.1% 0 64
Chronic sinusitis 64 79.0% 0 64
Dyspepsia 64 79.0% 0 64
Infusion related reaction 64 79.0% 0 64
Malaise 64 79.0% 0 64
Procedural pain 64 79.0% 0 64
Therapeutic product effect incomplete 64 79.0% 0 64
Female genital tract fistula 63 77.8% 0 63
Nausea 63 77.8% 0 63
Off label use 63 77.8% 0 63
Paraesthesia oral 63 77.8% 0 63
Pyrexia 63 77.8% 0 63
Weight decreased 63 77.8% 0 63
Abdominal pain 62 76.5% 0 62
Anaemia 62 76.5% 0 62
Colitis 62 76.5% 0 62
Constipation 62 76.5% 0 62
Erythema 62 76.5% 0 62
Frequent bowel movements 62 76.5% 0 62
Rectal haemorrhage 62 76.5% 0 62

Who Reports CLOFIBRATE Side Effects? Age & Gender Data

Gender: 97.3% female, 2.7% male. Average age: 69.7 years. Most reports from: CA. View detailed demographics →

Is CLOFIBRATE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2014 10 0 1
2016 1 0 1
2018 8 0 8
2023 1 0 0

View full timeline →

What Is CLOFIBRATE Used For?

IndicationReports
Product used for unknown indication 65
Blood cholesterol increased 9

Official FDA Label for CLOFIBRATE

Official prescribing information from the FDA-approved drug label.